Abstract:Background SENP1 (Sentrin-specific protease 1) is involved in heart disease by regulating intracellular SUMOylation. However, the role of cell type-specific SENP1 in the setting of myocardial infarction (MI) remains to be defined. We determined whether cardiomyocyte-specific SENP1 regulates maladaptive remodeling in the ischemic heart. Methods We generated cardiomyocyte-specific SENP1 knockout and overexpression mice to assess cardiac function and ventricular remodeling responses under physiological and pathological conditions. Adult mouse cardiomyocytes and fibroblasts were separated to observe the paracrine effects of cardiomyocytes. DIA proteomic assay and bioinformatic analysis were performed to detect differential proteins in primary cardiomyocytes. Single-cell sequencing data were analyzed to identify key cardiomyocyte cluster regulated by SENP1 after MI. Mass spectrometry was performed to search for key effector proteins regulated by SENP1. Results SENP1 expression reduced in post-infarction mice and patients with heart failure. Cardiomyocyte-specific SENP1 deficiency (genetic or adeno-associated virus (AAV)-mediated) triggered a myocardial fibrotic response and progressive cardiac dysfunction. MI exacerbated the poor ventricular remodeling response mediated by SENP1 deletion, SENP1 overexpression improved cardiac function and reduced fibrosis. Further, we found that increased cardiac fibrosis in the cardiomyocyte-specific SENP1 deletion mice, associated with increased Fn expression and secretion in cardiomyocytes, promoted fibroblast activation in response to myocardial injury. Mechanistically, SENP promoted deSUMOylation of the HSP90ab1 (heat shock protein 90 alpha, class B, member 1) Lys72 and ubiquitin-dependent degradation, which reduced HSP90ab1-mediated phosphorylation of STAT3 (signal transducer and activator of transcription 3) and transcriptional activation of Fn, and then reduced fibroblast activation in the indirect coculture model. On the other hand, AAV-mediated mutation of the HSP90ab1 Lys72 ameliorated adverse ventricular remodeling and dysfunction post-MI. Conclusions SENP1 is essential for repressing STAT3-mediated Fn transcription by regulating deSUMOylation of HSP90ab1. Blockade of HSP90ab1 SUMOylation at the Lys72 site is a novel therapy effective in reversing adverse ventricular remodeling post-MI. ![Figure][1] ### Competing Interest Statement The authors have declared no competing interest. * α-SMA : α-smooth muscle actin CTNT : cardiac troponin T ECM : extracellular matrix EF : ejection fraction FAKs : focal adhesion kinases FS : fraction shortening HSP90 : heat shock protein 90 MI : myocardial infarction MYH6 : myosin heavy chain 6 POSTN : periostin SENP : sentrin-specific protease STAT3 : signal transducer and activator of transcription 3 SUMO : small ubiquitin-like modifier [1]: pending:yes

LARP7 Protects Against Heart Failure by Enhancing Mitochondrial Biogenesis

Cardiomyocytes Deficiency of SENP1 Promotes Myocardial Fibrosis Via Paracrine Action

LARP7 overexpression alleviates aortic senescence and atherosclerosis

The role and mechanism of LARP7 in regulating the STING-dependent autophagy-lysosomal negative feedback loop in diabetic cardiomyopathy

LncRNA LncHrt preserves cardiac metabolic homeostasis and heart function by modulating the LKB1-AMPK signaling pathway

LARP7 ameliorates cellular senescence and aging by allosterically enhancing SIRT1 deacetylase activity

Cardiomyocyte-specific loss of RNA polymerase II subunit 5-mediating protein causes myocardial dysfunction and heart failure

LARP7 Suppresses Endothelial-to-Mesenchymal Transition by Coupling with TRIM28

Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention.

LARP7 Contributes to Glucose-Induced Cardiac Dysfunction, Apoptosis and Fibrosis by Inhibiting the Degradation of STING

Low-density lipoprotein receptor-related protein 6 regulates cardiomyocyte-derived paracrine signaling to ameliorate cardiac fibrosis

LRP6 downregulation promotes cardiomyocyte proliferation and heart regeneration

Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction

Abstract 274: Mitochondrial Translation Machinery Defects Causes Cardiomyopathy and I N Vivo Functional Screening of Therapeutic Targets

Larixyl acetate, a TRPC6 inhibitor, attenuates pressure overload‐induced heart failure in mice

FBXL4 Protects Against HFpEF Through Drp1-Mediated Regulation of Mitochondrial Dynamics and the Downstream SERCA2a

Reduced Mitochondrial Protein Translation Promotes Cardiomyocyte Proliferation and Heart Regeneration

Ranolazine Rescues the Heart Failure Phenotype of PLN-deficient Human Pluripotent Stem Cell-Derived Cardiomyocytes

Abstract 18772: Transient Receptor Potential Cation Channel 6 (TRPC6) Deficiency Preserves Cardiac Mitochondrial Respiration and Attenuates Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction

The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9‐Mediated Splicing of NFATc4

Sirtuin 7 ameliorates cuproptosis, myocardial remodeling and heart dysfunction in hypertension through the modulation of YAP/ATP7A signaling